A detailed history of Barclays PLC transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Barclays PLC holds 162,772 shares of BHC stock, worth $1.38 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
162,772
Previous 221,791 26.61%
Holding current value
$1.38 Million
Previous $1.54 Million 14.05%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$5.22 - $8.26 $308,079 - $487,496
-59,019 Reduced 26.61%
162,772 $1.33 Million
Q2 2024

Aug 14, 2024

SELL
$6.1 - $10.41 $1.84 Million - $3.14 Million
-301,454 Reduced 57.61%
221,791 $1.54 Million
Q1 2024

May 15, 2024

SELL
$7.77 - $10.61 $2.45 Million - $3.35 Million
-315,541 Reduced 37.62%
523,245 $5.55 Million
Q4 2023

Feb 15, 2024

BUY
$6.53 - $8.23 $1.3 Million - $1.63 Million
198,577 Added 31.02%
838,786 $6.73 Million
Q3 2023

Nov 07, 2023

SELL
$7.69 - $9.71 $2.41 Million - $3.05 Million
-314,017 Reduced 32.91%
640,209 $5.26 Million
Q2 2023

Aug 03, 2023

BUY
$5.72 - $8.8 $3.63 Million - $5.58 Million
634,551 Added 198.5%
954,226 $7.63 Million
Q1 2023

May 04, 2023

BUY
$6.28 - $9.85 $5,802 - $9,101
924 Added 0.29%
319,675 $2.59 Million
Q4 2022

Feb 13, 2023

SELL
$6.09 - $7.93 $4.06 Million - $5.29 Million
-666,550 Reduced 67.65%
318,751 $2 Million
Q3 2022

Nov 03, 2022

BUY
$4.58 - $9.21 $4.28 Million - $8.62 Million
935,470 Added 1877.29%
985,301 $6.79 Million
Q2 2022

Aug 12, 2022

BUY
$7.06 - $23.63 $327,301 - $1.1 Million
46,360 Added 1335.64%
49,831 $417,000
Q1 2022

May 16, 2022

SELL
$21.6 - $27.79 $2.18 Million - $2.81 Million
-101,097 Reduced 96.68%
3,471 $79,000
Q4 2021

Feb 14, 2022

SELL
$23.0 - $29.01 $465,865 - $587,597
-20,255 Reduced 16.23%
104,568 $2.89 Million
Q3 2021

Nov 09, 2021

SELL
$25.04 - $30.06 $892,901 - $1.07 Million
-35,659 Reduced 22.22%
124,823 $3.48 Million
Q2 2021

Aug 13, 2021

BUY
$27.43 - $32.7 $323,591 - $385,761
11,797 Added 7.93%
160,482 $4.71 Million
Q1 2021

May 13, 2021

BUY
$21.37 - $34.38 $3.01 Million - $4.85 Million
140,974 Added 1828.22%
148,685 $4.72 Million
Q4 2020

Feb 11, 2021

SELL
$15.31 - $21.12 $34.9 Million - $48.2 Million
-2,280,873 Reduced 99.66%
7,711 $159,000
Q3 2020

Nov 12, 2020

BUY
$14.88 - $20.13 $34 Million - $46 Million
2,283,707 Added 46826.06%
2,288,584 $35.6 Million
Q2 2020

Aug 12, 2020

SELL
$13.31 - $20.51 $3.35 Million - $5.16 Million
-251,714 Reduced 98.1%
4,877 $89,000
Q1 2020

May 13, 2020

BUY
$12.98 - $30.25 $1.71 Million - $3.98 Million
131,466 Added 105.07%
256,591 $3.98 Million
Q4 2019

Feb 10, 2020

SELL
$18.89 - $31.89 $2.27 Million - $3.84 Million
-120,406 Reduced 49.04%
125,125 $3.74 Million
Q3 2019

Nov 14, 2019

BUY
$20.88 - $25.66 $2.09 Million - $2.57 Million
100,167 Added 68.91%
245,531 $5.36 Million
Q2 2019

Aug 14, 2019

SELL
$20.52 - $26.45 $5.52 Million - $7.12 Million
-269,108 Reduced 64.93%
145,364 $3.67 Million
Q1 2019

May 15, 2019

SELL
$20.23 - $26.29 $2.83 Million - $3.67 Million
-139,686 Reduced 25.21%
414,472 $10.2 Million
Q4 2018

Feb 14, 2019

BUY
$17.64 - $28.32 $4.86 Million - $7.81 Million
275,642 Added 98.97%
554,158 $10.2 Million
Q3 2018

Nov 14, 2018

BUY
$20.64 - $25.67 $5.75 Million - $7.15 Million
278,516 New
278,516 $7.15 Million

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $3.07B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.